Skip to main content

Want a detailed portfolio tracker?

Humacyte (HUMA) P/E (2021 - 2026)

Humacyte (HUMA) P/E from Sep 30, 2021 to Jul 21, 2026. The TTM Humacyte (HUMA) P/E is -1.20. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Humacyte (HUMA)

YearP/EChange
2026-1.20-71.60%
2025-4.23+2.99%
2024-4.10+24.92%
2023-3.28-151.95%
20226.32-90.66%
202167.70N/A

Comparison Humacyte (HUMA) P/E with competitors

Humacyte (HUMA) P/E is -1.20.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.14%
NBYStablecoin Development Corp0.00-100.36%
ENLVEnlivex Ltd0.07-106.23%
FGENFibroGen Inc0.24-120.00%
CHRSCoherus Biosciences Inc0.85-170.71%
FBIOFortress Biotech Inc0.95-179.08%
ORMPOramed Pharmaceuticals Inc1.50-225.25%
AGENAgenus Inc3.01-350.78%
INVAInnoviva Inc3.15-362.82%
VXRTVaxart Inc3.55-395.79%
CRMDCorMedix Inc3.63-402.35%
CVACCureVac N.V.4.45-470.45%
GLPGGalapagos NV4.86-504.88%
SRPTSarepta Therapeutics Inc4.88-506.81%
ABEOAbeona Therapeutics Inc5.39-548.93%
ABUSArbutus Biopharma Corp5.60-566.27%
ZVRAZevra Therapeutics Inc5.89-590.57%
SPROSpero Therapeutics Inc6.23-619.00%
CGENCompugen Ltd6.31-626.12%
RIGLRigel Pharmaceuticals6.87-672.63%
SLXNSilexion Therapeutics Corp7.30-707.96%
OMEROmeros Corporation9.26-871.51%
AUPHAurinia Pharmaceuticals Inc9.58-898.69%
PLXProtalix BioTherapeutics Inc10.89-1007.52%
ACADAcadia Pharmaceuticals Inc11.73-1077.31%
TBPHTheravance Biopharma Inc12.26-1121.77%
ADMAAdma Biologics Inc12.42-1134.77%
HRMYHarmony Biosciences Holdings Inc13.82-1251.60%
SABSSAB Biotherapeutics Inc14.14-1277.93%
NAGENiagen Bioscience Inc14.82-1334.76%
INCYIncyte Corp15.82-1418.45%
REGNRegeneron Pharmaceuticals Inc15.86-1421.30%
PBYIPuma Biotechnology Inc17.32-1542.87%
CPRXCatalyst Pharmaceuticals Inc17.44-1553.17%
EXELExelixis Inc17.54-1561.40%
TGTXTG Therapeutics Inc18.97-1680.39%
MDXGMimedx Group Inc20.55-1812.59%
XOMAXOMA Royalty Corp22.87-2006.14%
ARGXArgen X SE24.30-2124.75%
CTMXCytomX Therapeutics Inc24.82-2168.34%
XOMAOXOMA Royalty Corp25.34-2211.98%
HALOHalozyme Therapeutics Inc25.62-2235.22%
XOMAPXOMA Royalty Corp25.67-2239.08%
VRTXVertex Pharmaceuticals Inc27.99-2432.79%
RPRXRoyalty Pharma plc - Class A28.69-2490.52%
SLNOSoleno Therapeutics Inc29.02-2517.84%
ASNDAscendis Pharma A/S30.09-2607.02%
LGNDLigand Pharmaceuticals Inc - Class B37.91-3259.20%
APLSApellis Pharmaceuticals Inc39.02-3351.63%
BMRNBiomarin Pharmaceutical Inc42.21-3617.50%
KRYSKrystal Biotech Inc45.34-3878.46%
ONCBeiGene Ltd69.54-5894.79%
PHARPharming Group N.V.75.03-6351.86%
TECHBio-Techne Corp101.96-8596.17%
VCELVericel Corp109.92-9259.72%
ALNYAlnylam Pharmaceuticals Inc117.96-9930.00%
GMABGenmab140.29-11790.40%
TLXTelix Pharmaceuticals Ltd162.15-13612.16%
CORTCorcept Therapeutics Inc212.86-17837.37%